Eloxx Pharmaceuticals Management
Management criteria checks 3/4
Eloxx Pharmaceuticals' CEO is Sumit Aggarwal, appointed in Apr 2021, has a tenure of 3.08 years. total yearly compensation is $1.40M, comprised of 41.2% salary and 58.8% bonuses, including company stock and options. directly owns 0.15% of the company’s shares, worth $4.74K. The average tenure of the management team and the board of directors is 3.1 years and 6 years respectively.
Key information
Sumit Aggarwal
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 41.2% |
| CEO tenure | 3.1yrs |
| CEO ownership | 0.1% |
| Management average tenure | 3.1yrs |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
Eloxx says lead asset failed in mid-stage cystic fibrosis trial
Sep 14Eloxx Pharmaceuticals GAAP EPS of -$0.12 in-line
Aug 15Is Eloxx Pharmaceuticals (NASDAQ:ELOX) Using Debt In A Risky Way?
Sep 09
Eloxx Pharmaceuticals EPS misses by $0.06
May 06What Kind Of Investors Own Most Of Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX)?
Feb 17Eloxx secures additional funding from CF Foundation for ELX-02 mid-stage study in cystic fibrosis
Jan 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$20m |
| Jun 30 2023 | n/a | n/a | -US$24m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$1m | US$575k | -US$36m |
| Sep 30 2022 | n/a | n/a | -US$42m |
| Jun 30 2022 | n/a | n/a | -US$44m |
| Mar 31 2022 | n/a | n/a | -US$70m |
| Dec 31 2021 | US$6m | US$408k | -US$67m |
Compensation vs Market: Sumit's total compensation ($USD1.40M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Sumit's compensation has been consistent with company performance over the past year.
CEO
Sumit Aggarwal (50 yo)
3.1yrs
Tenure
US$1,395,942
Compensation
Mr. Sumit Aggarwal, MBA serves as a Director at Eloxx Pharmaceuticals, Inc. since April 01, 2021. He is the President and Chief Executive Officer of Eloxx Pharmaceuticals, Inc. since April 01, 2021. He ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.1yrs | US$1.40m | 0.15% $ 4.7k | |
| Interim CFO | 3.1yrs | US$63.96k | 0.038% $ 1.2k | |
| Investor Relations Officer | no data | no data | no data | |
| Chief Medical Officer | 2.5yrs | no data | no data |
3.1yrs
Average Tenure
Experienced Management: ELOX's management team is considered experienced (3.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.1yrs | US$1.40m | 0.15% $ 4.7k | |
| Independent Director | 6.4yrs | US$58.60k | 0% $ 0 | |
| Independent Director | 3.1yrs | US$61.10k | 0.029% $ 905.3 | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 6yrs | no data | no data | |
| Member of Scientific Advisory Board | 6yrs | no data | no data | |
| Member of Scientific Advisory Board | 6yrs | no data | no data | |
| Member of Scientific Advisory Board | 6yrs | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data |
6.0yrs
Average Tenure
59.5yo
Average Age
Experienced Board: ELOX's board of directors are considered experienced (6 years average tenure).